Explore the Global Lung Cancer Therapeutics Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Lung Cancer Therapeutics Market

Key Insight

The lung cancer therapeutics market was valued at USD 41.8 billion in 2025, is projected to reach USD 141.2 billion by 2036 and is forecast to register an 11.7% CAGR between 2026 and 2036, creating an incremental opportunity of USD 94.5 billion. In 2026, targeted therapies hold 91.2% of the drug class category.

May 11, 2026

Anurag Sharma

250 Pages

Cite this Report

Lung Cancer Therapeutics Market

https://www.futuremarketinsights.com/reports/lung-cancer-therapeutics-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Amgen
BlackRock
Boehringer Ingelheim
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb
Eli Lilly and Company
F. Hoffmann-La Roche Ag
Merck KGaA
Novartis
The Vanguard Group
Specialist Players
Takeda
Takeda Pharmaceutical Company Limited

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Lung Cancer Therapeutics Market

Key Players

Similar Industry Reports